Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amnipur Technology is a specialized bioprocessing company focused on downstream purification solutions for the global biopharmaceutical industry. The company develops and manufactures a comprehensive range of chromatography resins, including Protein A, ion exchange, and hydrophobic interaction media, marketed under the AmniSep brand. In addition to consumables, Amnipur provides automated purification systems and pre-packed columns designed to streamline the production of monoclonal antibodies, vaccines, and recombinant proteins. Headquartered in Suzhou, China, the firm serves as a critical supplier in the biologics manufacturing supply chain, offering high-performance alternatives to traditional bioprocessing tools. The company was founded by industry veterans with extensive experience in global life science tool providers, aiming to localize high-end manufacturing technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amnipur Technology.